Rafael Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Smaller biotech companies are also making some big advances and contributions in the fight against cancer.

GlycoMimetics, Inc. (NASDAQ:NASDAQ:GLYC) Q1 2022 Results Conference Call April 28, 2022 08:30 AM ET Company Participants Shari Annes - IR Harout Semerjian - CEO Brian Hahn - CFO Armand...

GLYC earnings call for the period ending March 31, 2022.

Old West: “Investment in Rafael Holdings (RFL) Represents an Extremely Asymmetric Opportunity” Old West Investment Management, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. An average  return of 25% was delivered by the fund for the Q1 of 2021, ahead of its S&P 500 benchmark that delivered a 6% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021. Old West Investment Management, in their Q1 2021 investor letter, mentioned Rafael Holdings, Inc. (NYSE: RF...

Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO Leadership Team Will Build on Pharma Investments News provided by Share this article Share this article NEWARK, N.J., March 11, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), today announced that its Board of Directors has recruited Ameet Mallik to become the company's Chief Executive Officer, succeeding its founder, Howard Jonas.  Ameet Mallik's appointment will become effective May 1, 2021.  In addition, William "Bill" Conkling has been named Chief Commercial Officer ef...